Shanna Babalonis, Ph.D. is an Assistant Professor in the Department of Behavioral Science and Center for Drug and Alcohol Research in the College of Medicine at the University of Kentucky. Over the past 10 years, she has completed studies in the human laboratory and the clinic that focus on the assessment of novel pharmacotherapies for the treatment of opioid and cannabis use disorders. In the human laboratory, she has conducted studies on the abuse liability of several classes of medications, most commonly prescription opioids and cannabinoids, including pharmaceutical cannabinoids and smoked cannabis. She is the PI on two NIH-funded projects that examine the effects of smoked cannabis on outcomes related to driving impairment and opioid/cannabinoid interaction effects. She co-authored a report on cannabidiol for the World Health Organization and presented the results to the annual meeting of the Expert Committee on Drug Dependence in Geneva, Switzerland. She is also an active member of the Council on Government Relations Cannabis and Hemp Research Working Group and has served as a consultant on current topics in cannabis science for the Kentucky state legislature, the Kentucky Board of Nursing and several universities and government entities.